Chemed Corporation $CHE Shares Acquired by SG Americas Securities LLC

SG Americas Securities LLC lifted its stake in shares of Chemed Corporation (NYSE:CHE) by 773.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 26,466 shares of the company’s stock after acquiring an additional 23,436 shares during the quarter. SG Americas Securities LLC owned 0.19% of Chemed worth $11,324,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also modified their holdings of CHE. Geneos Wealth Management Inc. grew its stake in Chemed by 330.4% during the 1st quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after purchasing an additional 76 shares in the last quarter. Cetera Investment Advisers raised its position in Chemed by 1.5% in the 2nd quarter. Cetera Investment Advisers now owns 1,740 shares of the company’s stock valued at $847,000 after purchasing an additional 25 shares in the last quarter. Legal & General Group Plc boosted its stake in shares of Chemed by 4.0% in the 2nd quarter. Legal & General Group Plc now owns 31,642 shares of the company’s stock valued at $15,419,000 after buying an additional 1,206 shares during the period. Franklin Resources Inc. boosted its stake in shares of Chemed by 9.9% in the 2nd quarter. Franklin Resources Inc. now owns 19,077 shares of the company’s stock valued at $9,289,000 after buying an additional 1,713 shares during the period. Finally, Prudential Financial Inc. grew its position in shares of Chemed by 27.7% during the second quarter. Prudential Financial Inc. now owns 1,679 shares of the company’s stock worth $818,000 after buying an additional 364 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Chemed Price Performance

NYSE CHE opened at $368.42 on Monday. The company has a fifty day moving average of $428.15 and a two-hundred day moving average of $435.22. The company has a market capitalization of $5.07 billion, a PE ratio of 20.06, a P/E/G ratio of 1.46 and a beta of 0.47. Chemed Corporation has a 1 year low of $365.20 and a 1 year high of $623.60.

Chemed (NYSE:CHE) last posted its earnings results on Wednesday, February 25th. The company reported $6.42 EPS for the quarter, missing analysts’ consensus estimates of $7.02 by ($0.60). The firm had revenue of $639.34 million for the quarter, compared to analyst estimates of $659.09 million. Chemed had a return on equity of 25.66% and a net margin of 10.48%.The firm’s revenue for the quarter was down .1% on a year-over-year basis. During the same quarter last year, the firm posted $6.83 EPS. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. On average, research analysts expect that Chemed Corporation will post 21.43 earnings per share for the current year.

Chemed Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 13th. Stockholders of record on Monday, February 23rd were issued a $0.60 dividend. This represents a $2.40 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend was Monday, February 23rd. Chemed’s dividend payout ratio is presently 13.06%.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Weiss Ratings restated a “hold (c-)” rating on shares of Chemed in a research note on Wednesday, January 21st. Royal Bank Of Canada reiterated a “sector perform” rating and set a $422.00 price target (down from $572.00) on shares of Chemed in a report on Friday, February 27th. Jefferies Financial Group downgraded shares of Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd. Oppenheimer reduced their price objective on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a report on Friday, February 27th. Finally, Zacks Research cut shares of Chemed from a “hold” rating to a “strong sell” rating in a research report on Wednesday, March 4th. Two research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Chemed presently has a consensus rating of “Hold” and a consensus target price of $498.00.

Insider Activity

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction on Thursday, March 12th. The shares were sold at an average price of $403.18, for a total value of $806,360.00. Following the transaction, the chief executive officer directly owned 93,719 shares of the company’s stock, valued at $37,785,626.42. The trade was a 2.09% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 3.29% of the company’s stock.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.